PTC Therapeutics | PTCT - 营业费用

股票价格
68.23
每天变化
-0.36 -0.52%
每月一次
2.22%
每年
37.75%
Q2 预测
66.77


金融业
股票价格
USD
资产
USD 2.9B
现金及等价物
USD 984.65M
销售成本
USD 16.3M
流动资产
USD 2.27B
流动负债
USD 968.43M
债务
USD 2.71B
EBIT
USD -81.62M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -1.67
股本和储备
USD -205.31M
销售毛利
USD 148.38M
债务利息支出
USD 50.58M
贷款资金
USD 2.03B
市值
USD 5.25B
净收入
USD -134.97M
营业费用
USD 246.3M
营业利润
USD -81.62M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -139.08M
销售收入
USD 164.7M
销售和管理费用
USD 87.2M
股票
USD 79.65M
贸易债权人
USD 45.49M
应收帐款人
USD 181.62M


营业费用 更改 日
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
BioCryst Pharmaceuticals USD 146.17M 534.06M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Novartis USD 9.8B 61M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xencor USD 81.86M 13.35M 2025-12